Stay updated with breaking news from Cabotegravir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
12-month findings from the SOLAR study showed that the every-two-month regimen of CAB+RPV LA demonstrated non-inferior efficacy compared to continuation of daily oral BIC/FTC/TAF 90% of participants ....